Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation

Author
Vatansever, S.
Aydiner, A.
Khanmamadov, N.
Saip, P.
Demirkazik, A.
Dogan, I.
Gurbuz, M.
Paksoy, N.
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/171760
https://doi.org/10.1016/j.annonc.2021.08.2015
Collections